Project Grant R43DC022211
Award Date
6/17/25
Completion Date
6/30/26
Dollars Obligated
$308K
Similar Awards
This $145,989 Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) will support research to investigate the neural basis of tinnitus and hyperacusis. The award, spanning May 2025 through April 2030, will enable the University of Rochester to utilize advanced in vivo imaging techniques in animal models to determine whether altered cell-specific activity or...
This Project Grant award, valued at $1,008,234.00, was provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173). The award supports research at the University of Pittsburgh focused on identifying objective neural correlates of different forms of subjective tinnitus, including non-somatic tinnitus and somatic (somatosensory/trigeminal) tinnitus. The research aims to use...
This STTR Phase I Project Grant awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD) under CFDA 93.173 provides $305,197 to VDF Industries Inc. to develop a novel endovascular medical device called "Phonocath" to improve the diagnosis of pulsatile tinnitus (PT). The project aims to design and prototype a low-profile microcatheter device with advanced microsensor technology to objectively assess the source of PT, a form of tinnitus characterized by a...
This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $131,408 to the Massachusetts Eye and Ear Infirmary to investigate the neurological impacts of noise-induced hearing loss. The research aims to leverage advanced neuroscience techniques like two-photon calcium imaging and optogenetics to track changes in auditory cortex and...
This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $134,730 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct research on subtyping tinnitus based on functional magnetic resonance imaging (fMRI) dynamic functional connectivity. The key objectives of this 2-year project are to: 1) Subtype...
The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $275,371 Project Grant (CFDA 93.173) to Auricle Health Inc. to develop an extracochlear device to restore hearing for patients with sensorineural hearing loss (SNHL). The funding will support refinement of the electrode design, demonstration of electrical stimulation of the cochlear nerve in animal models, and evaluation of the long-term safety and durability of the implant. This project aims to create a...
This Project Grant award of $713,170 from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), will fund the development and validation of a Multimodality Micro-Optical Coherence Tomography (MM-MOCT) technology. This innovative imaging system will obtain high-resolution structural and metabolic information about the critical sensorineural cells and nerve fibers in the human cochlea....
This federal Project Grant award of $610,725.00 was provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders (CFDA 93.173) program. The grant will fund research to characterize the effects of distorted tonotopy and central plasticity on neural coding and perception of speech-in-noise for individuals with sensorineural hearing loss. The research aims to develop personalized hearing loss profiles...
This Project Grant award of $305,628 from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) will support Echogenesis Therapeutics Inc.'s development of a cell-type-specific gene therapy approach for TOMT-linked congenital hearing loss. The project aims to establish proof-of-concept for a precision medicine therapy that can precisely target cochlear hair cells to restore hearing...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD) under CFDA 93.173 "Research Related to Deafness and Communication Disorders" is funding research at Oregon Health & Science University (OHSU) to investigate binaural integration of spectral and temporal information in individuals with hearing loss and hearing devices. The $662,162 award, effective April 4, 2025 through March 31, 2030, aims to address gaps in understanding...